Angela Hwang's most recent trade in United Parcel Service, Inc. - Ordinary Shares - Class B was a trade of 2,011 Restricted Stock Units done . Disclosure was reported to the exchange on May 8, 2025.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| United Parcel Service | Angela Hwang | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 May 2025 | 2,011 | 7,870 | - | - | Restricted Stock Units | |
| United Parcel Service | Angela Hwang | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 May 2024 | 1,256 | 5,569 | - | - | Restricted Stock Units | |
| Pfizer | Angela Hwang | President, Global Biopharma | 10 May 2023 | 33,943 | 69,046 | - | - | Phantom Stock Units SSP | ||
| United Parcel Service | Angela Hwang | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 May 2023 | 1,038 | 4,143 | - | - | Restricted Stock Units | |
| Pfizer | Angela Hwang | President, Global Biopharma | Exercise or conversion of derivative security received from the company (such as an option) at price $ 22.89 per share. | 25 Feb 2023 | 20,273 | 44,541 (0%) | 0% | 22.9 | 464,049 | Common Stock |
| Pfizer | Angela Hwang | President, Global Biopharma | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 25 Feb 2023 | 20,273 | 0 | - | - | Stock Appreciation Rights | |
| Pfizer | Angela Hwang | President, Global Biopharma | Payment of exercise price or tax liability using portion of securities received from the company at price $ 43.44 per share. | 25 Feb 2023 | 9,015 | 29,778 (0%) | 0% | 43.4 | 391,612 | Common Stock |
| Pfizer | Angela Hwang | President, Global Biopharma | Payment of exercise price or tax liability using portion of securities received from the company at price $ 41.75 per share. | 25 Feb 2023 | 5,748 | 38,793 (0%) | 0% | 41.8 | 239,979 | Common Stock |
| Pfizer | Angela Hwang | President, Global Biopharmaceu | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 22 Feb 2023 | 103,320 | 103,320 | - | - | Stock Appreciation Rights | |
| Pfizer | Angela Hwang | President, Global Biopharmaceu | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 22 Feb 2023 | 89,920 | 89,920 | - | - | Stock Appreciation Rights | |
| Pfizer | Angela Hwang | President, Global Biopharmaceu | Exercise or conversion of derivative security received from the company (such as an option) at price $ 30.17 per share. | 22 Feb 2023 | 57,032 | 67,027 (0%) | 0% | 30.2 | 1,720,655 | Common Stock |
| Pfizer | Angela Hwang | President, Global Biopharmaceu | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 22 Feb 2023 | 57,032 | 0 | - | - | Stock Appreciation Rights | |
| Pfizer | Angela Hwang | President, Global Biopharmaceu | Payment of exercise price or tax liability using portion of securities received from the company at price $ 43.70 per share. | 22 Feb 2023 | 34,718 | 24,268 (0%) | 0% | 43.7 | 1,517,177 | Common Stock |
| Pfizer | Angela Hwang | President, Global Biopharmaceu | Payment of exercise price or tax liability using portion of securities received from the company at price $ 42.38 per share. | 22 Feb 2023 | 8,041 | 58,986 (0%) | 0% | 42.4 | 340,778 | Common Stock |
| United Parcel Service | Angela Hwang | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 May 2022 | 973 | 3,004 | - | - | Restricted Stock Units | |
| Pfizer | Angela Hwang | Group President | Exercise or conversion of derivative security received from the company (such as an option) at price $ 25.60 per share. | 26 Feb 2022 | 12,716 | 19,393 (0%) | 0% | 25.6 | 325,530 | Common Stock |
| Pfizer | Angela Hwang | Group President | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 26 Feb 2022 | 12,716 | 0 | - | - | Stock Appreciation Rights | |
| Pfizer | Angela Hwang | Group President | Payment of exercise price or tax liability using portion of securities received from the company at price $ 50.64 per share. | 26 Feb 2022 | 5,937 | 9,995 (0%) | 0% | 50.6 | 300,650 | Common Stock |
| Pfizer | Angela Hwang | Group President | Payment of exercise price or tax liability using portion of securities received from the company at price $ 47.72 per share. | 26 Feb 2022 | 3,461 | 15,932 (0%) | 0% | 47.7 | 165,159 | Common Stock |
| Pfizer | Angela Hwang | Group President | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 Feb 2022 | 95,095 | 95,095 | - | - | Stock Appreciation Rights | |
| Pfizer | Angela Hwang | Group President | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 Feb 2022 | 83,637 | 83,637 | - | - | Stock Appreciation Rights | |
| Pfizer | Angela Hwang | Group President | Exercise or conversion of derivative security received from the company (such as an option) at price $ 27.34 per share. | 23 Feb 2022 | 21,359 | 21,359 (0%) | 0% | 27.3 | 583,955 | Common Stock |
| Pfizer | Angela Hwang | Group President | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 23 Feb 2022 | 21,359 | 0 | - | - | Stock Appreciation Rights | |
| Pfizer | Angela Hwang | Group President | Payment of exercise price or tax liability using portion of securities received from the company at price $ 51.28 per share. | 23 Feb 2022 | 10,572 | 6,677 (0%) | 0% | 51.3 | 542,132 | Common Stock |
| Pfizer | Angela Hwang | Group President | Payment of exercise price or tax liability using portion of securities received from the company at price $ 46.87 per share. | 23 Feb 2022 | 4,110 | 17,249 (0%) | 0% | 46.9 | 192,636 | Common Stock |
| Pfizer | Angela Hwang | Group President | 12 Nov 2021 | 18,098 | 33,576 | - | - | Phantom Stock Units SSP | ||
| Pfizer | Angela Hwang | Group President | Sale of securities on an exchange or to another person at price $ 49.60 per share. | 12 Nov 2021 | 11,312 | 1 (0%) | 0% | 49.6 | 561,075 | Common Stock |
| Pfizer | Angela Hwang | Group President | Sale of securities on an exchange or to another person at price $ 49.59 per share. | 12 Nov 2021 | 10,646 | 11,313 (0%) | 0% | 49.6 | 527,935 | Common Stock |
| Pfizer | Angela Hwang | Group President | Sale of securities on an exchange or to another person at price $ 49.62 per share. | 12 Nov 2021 | 3,412 | 21,959 (0%) | 0% | 49.6 | 169,303 | Common Stock |
| Pfizer | Angela Hwang | Group President | Sale of securities on an exchange or to another person at price $ 49.61 per share. | 12 Nov 2021 | 800 | 25,371 (0%) | 0% | 49.6 | 39,688 | Common Stock |
| United Parcel Service | Angela Hwang | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 May 2021 | 811 | 1,986 | - | - | Restricted Stock Units | |
| Pfizer | Angela Hwang | Group President | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 27 Feb 2021 | 9,886 | 0 | - | - | Stock Appreciation Rights | |
| Pfizer | Angela Hwang | Group President | Exercise or conversion of derivative security received from the company (such as an option) at price $ 22.35 per share. | 27 Feb 2021 | 9,886 | 34,211 (0%) | 0% | 22.3 | 220,952 | Common Stock |
| Pfizer | Angela Hwang | Group President | Payment of exercise price or tax liability using portion of securities received from the company at price $ 34.64 per share. | 27 Feb 2021 | 6,268 | 26,171 (0%) | 0% | 34.6 | 217,124 | Common Stock |
| Pfizer | Angela Hwang | Group President | Payment of exercise price or tax liability using portion of securities received from the company at price $ 33.49 per share. | 27 Feb 2021 | 1,772 | 32,439 (0%) | 0% | 33.5 | 59,344 | Common Stock |
| Pfizer | Angela Hwang | Group President | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 Feb 2021 | 158,023 | 158,023 | - | - | Stock Appreciation Rights | |
| Pfizer | Angela Hwang | Group President | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 Feb 2021 | 136,537 | 136,537 | - | - | Stock Appreciation Rights | |
| Pfizer | Angela Hwang | Group President | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 25 Feb 2021 | 22,686 | 0 | - | - | Stock Appreciation Rights | |
| Pfizer | Angela Hwang | Group President | Exercise or conversion of derivative security received from the company (such as an option) at price $ 22.89 per share. | 25 Feb 2021 | 22,686 | 42,927 (0%) | 0% | 22.9 | 519,283 | Common Stock |
| Pfizer | Angela Hwang | Group President | Payment of exercise price or tax liability using portion of securities received from the company at price $ 34.76 per share. | 25 Feb 2021 | 14,682 | 24,325 (0%) | 0% | 34.8 | 510,346 | Common Stock |
| Pfizer | Angela Hwang | Group President | Payment of exercise price or tax liability using portion of securities received from the company at price $ 33.82 per share. | 25 Feb 2021 | 3,920 | 39,007 (0%) | 0% | 33.8 | 132,574 | Common Stock |
| Pfizer | Angela Hwang | Group President | 16 Dec 2020 | 12,970 | 26,697 (0%) | 0% | 37.8 | 490,785 | Common Stock |